Spyre Therapeutics Inc. (SYRE)
undefined
undefined%
At close: undefined
24.12
0.12%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 886.00K 2.33M 18.74M - - 3.89M 5.21M 4.63M
Cost of Revenue 964.00K 1.96M 2.00M 1.62M 901.00K - - -
Gross Profit -78.00K 365.00K 16.74M -1.62M -901.00K 3.89M 5.21M 4.63M
Operating Income -242.30M -84.78M -65.65M -81.48M -80.33M -45.46M -27.68M -21.91M
Interest Income 6.15M 837.00K 111.00K 593.00K 2.14M 1.17M 482.00K 244.00K
Pretax Income -338.82M -83.95M -65.66M -80.89M -78.25M -44.35M -27.24M -21.70M
Net Income -338.79M -83.81M -65.80M -80.89M -78.25M -44.35M -27.24M -21.70M
Selling & General & Admin 39.95M 28.53M 27.32M 21.84M 14.83M 12.34M 9.82M 8.26M
Research & Development 89.50M 58.58M 57.07M 59.64M 64.60M 36.72M 22.82M 18.14M
Other Expenses 113.74M -7.00K -122.00K -5.00K - - - -
Operating Expenses 243.19M 87.11M 84.39M 81.48M 79.43M 49.06M 32.63M 26.40M
Interest Expense - - - - - - - -
Selling & Marketing Expenses - - - - - - - -
Cost & Expenses 243.19M 87.11M 84.39M 81.48M 80.33M 49.35M 32.88M 26.53M
Income Tax -26.00K -136.00K 141.00K -593.00K - - - -
Shares Outstanding (Basic) 6.90M 3.37M 2.63M 2.13M 1.28M 832.90K 605.13K 391.67K
Shares Outstanding (Diluted) 6.90M 3.37M 2.63M 2.13M 1.28M 832.90K 605.13K 391.67K
EPS (Basic) -49.12 -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 -55.4
EPS (Diluted) -49.12 -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 -55.4
EBITDA -127.82M -83.21M -63.66M -79.27M -77.35M -45.17M -27.43M -21.77M
Depreciation & Amortization 964.00K 1.96M 2.00M 1.62M 901.00K 293.00K 249.00K 132.00K